1. Home
  2. BNR vs APT Comparison

BNR vs APT Comparison

Compare BNR & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • APT
  • Stock Information
  • Founded
  • BNR 2014
  • APT 1983
  • Country
  • BNR China
  • APT Canada
  • Employees
  • BNR N/A
  • APT N/A
  • Industry
  • BNR Medical Specialities
  • APT
  • Sector
  • BNR Health Care
  • APT
  • Exchange
  • BNR Nasdaq
  • APT Nasdaq
  • Market Cap
  • BNR 69.6M
  • APT 61.6M
  • IPO Year
  • BNR 2020
  • APT 1995
  • Fundamental
  • Price
  • BNR $6.66
  • APT $5.43
  • Analyst Decision
  • BNR
  • APT
  • Analyst Count
  • BNR 0
  • APT 0
  • Target Price
  • BNR N/A
  • APT N/A
  • AVG Volume (30 Days)
  • BNR 5.1K
  • APT 29.4K
  • Earning Date
  • BNR 03-27-2025
  • APT 03-12-2025
  • Dividend Yield
  • BNR N/A
  • APT N/A
  • EPS Growth
  • BNR N/A
  • APT 20.88
  • EPS
  • BNR N/A
  • APT 0.37
  • Revenue
  • BNR $72,832,704.00
  • APT $59,288,000.00
  • Revenue This Year
  • BNR $52.90
  • APT N/A
  • Revenue Next Year
  • BNR $48.35
  • APT N/A
  • P/E Ratio
  • BNR N/A
  • APT $14.33
  • Revenue Growth
  • BNR N/A
  • APT 1.88
  • 52 Week Low
  • BNR $2.62
  • APT $4.64
  • 52 Week High
  • BNR $8.99
  • APT $6.92
  • Technical
  • Relative Strength Index (RSI)
  • BNR 50.28
  • APT 43.52
  • Support Level
  • BNR $5.58
  • APT $5.30
  • Resistance Level
  • BNR $6.85
  • APT $5.50
  • Average True Range (ATR)
  • BNR 0.28
  • APT 0.19
  • MACD
  • BNR -0.06
  • APT -0.03
  • Stochastic Oscillator
  • BNR 62.01
  • APT 18.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.

Share on Social Networks: